[Ip-health] Perspectives on Cancer Drug Development Costs in JAMA | Bill of Health

Jamie Love james.love at keionline.org
Thu Sep 14 06:48:25 PDT 2017


These were some comments on the recent Prasad/Mailankody paper in Jama on
drug development costs.


http://blogs.harvard.edu/billofhealth/2017/09/13/perspectives-on-cancer-drug-development-costs-in-jama/



More information about the Ip-health mailing list